Injective INJ
Current Price
$3.52 +9.16%
$0.3200 Daily Range (9.09%)
$3.22$3.54
$102.84M Daily Volume
1,516 BTC
Vol/MktCap: 29.24%
Market Performance
0.20% Relative BTC Volume
The total volume of Injective is $102.84M over the past 24 hours, compared to $51.47B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.41 +3.36%
13 SMA $3.38 +4.27%
21 SMA $3.32 +5.89%
55 SMA $3.26 +7.90%
144 SMA $3.19 +10.42%
Price Performance
+2.33% 1 Hour Change
$3.52 from $3.44
+11.79% 7 Day Change
$0.4150 from $3.11
+6.99% 14 Day Change
$0.2461 from $3.27
-25.07% 30 Day Change
-$0.8823 from $4.40
All Time High
March 14, 2024
$52.62 -93.32%
-$49.10 vs. now
24H Change
29.31M USD +9.09%
432 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
30.43M INJ
traded over past 24 hours
30.43% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.54, reflecting a notable 10.82% increase over the last 24 hours. The daily trading range is relatively tight, with a high of $3.53 and a low of $3.20, indicating moderate volatility within this period.
The trading volume stands at 102,865,498, which corresponds to a volume-to-market cap ratio of 29.13%, suggesting healthy liquidity. Short-term moving averages are all in positive territory, with the 8 SMA at $3.41 (+3.95%) and the 13 SMA at $3.38 (+4.87%), indicating a bullish trend in the immediate market context.
The 1-hour RSI is at 79, signaling potential overbought conditions, while the 7-day RSI sits at 53, indicating a balanced momentum over the week. Recent price changes show a 12.50% increase over the past week, juxtaposed against a more significant 30-day decline of 24.59%, reflecting mixed short- and long-term trends.
Despite the recent price rally, the 30-day performance suggests caution as the asset has not regained its previous highs. The all-time high of $52.62 remains significantly above the current price, indicating potential upside but also highlighting the volatility and risk inherent in the asset.
Considering the current market conditions, the bullish sentiment reflected in short-term moving averages and recent price increases is tempered by overbought signals and longer-term declines. Therefore, the recommendation is to Hold Injective (INJ) at this time, awaiting further confirmation of sustained upward momentum and a potential correction in the RSI indicators.
The trading volume stands at 102,865,498, which corresponds to a volume-to-market cap ratio of 29.13%, suggesting healthy liquidity. Short-term moving averages are all in positive territory, with the 8 SMA at $3.41 (+3.95%) and the 13 SMA at $3.38 (+4.87%), indicating a bullish trend in the immediate market context.
The 1-hour RSI is at 79, signaling potential overbought conditions, while the 7-day RSI sits at 53, indicating a balanced momentum over the week. Recent price changes show a 12.50% increase over the past week, juxtaposed against a more significant 30-day decline of 24.59%, reflecting mixed short- and long-term trends.
Despite the recent price rally, the 30-day performance suggests caution as the asset has not regained its previous highs. The all-time high of $52.62 remains significantly above the current price, indicating potential upside but also highlighting the volatility and risk inherent in the asset.
Considering the current market conditions, the bullish sentiment reflected in short-term moving averages and recent price increases is tempered by overbought signals and longer-term declines. Therefore, the recommendation is to Hold Injective (INJ) at this time, awaiting further confirmation of sustained upward momentum and a potential correction in the RSI indicators.
Updated 12 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin and US Equities Spike After Supreme Court Ruling Voids Trump’s Tariff Regime
On Feb. 20, 2026, the U.S.

SCOTUS strikes down Trump tariffs, but 'alternative' plans brewing
US President Donald Trump has repeatedly said that tariffs could help pay down the $38 trillion, and growing, US national debt.

Opening the door: SEC issues guidance on brokers’ capital stablecoin requirements
The SEC introduced new guidance allowing broker-dealers to apply a “2% haircut” to proprietary positions in certain stablecoins.

Bryan Pellegrino: Base’s shift signals independence from OP Stack, why fragmentation is the future of blockchain, and the rising importance of interoperability for institutions | Unchained
Base's split from the OP Stack signals a pivotal shift in Ethereum's layer two…